99 Followers on Owler
OverviewCompetitorsFundingInvestmentsNews & Insights

Idorsia Competitors or Alternatives

Idorsia's top competitors include Rhizen, Clinuvel and Noema Pharma.

Unlock 19 more competitors →

RANK

COMPANY

CEO

CEO RATING

EMPLOYEES

FUNDING

REVENUE

  • FUNDING

    REVENUE

  • EMPLOYEES

    FUNDING

  • REVENUE

  • CEO RATING

  • EMPLOYEES

  • FUNDING

  • REVENUE

Idorsia's company profile

Andre Muller

CEO

83/100
689
$251.9M
$124.6M
  • $251.9M
    $124.6M
  • 689
    $251.9M
  • $124.6M
  • 83/100
  • 689
  • $251.9M
  • $124.6M
View ProfileView
1
Idorsia's Competitor - Rhizen logo

Swaroop Vakkalanka

President

70/100
1 - 25
- -
$5M - 25M
  • - -
    $5M - 25M
  • 1 - 25
    - -
  • $5M - 25M
  • 70/100
  • 1 - 25
  • - -
  • $5M - 25M
View ProfileView
2
Idorsia's Competitor - Clinuvel logo

Willem Blijdorp

CEO

90/100
27
- -
$58.8M
  • - -
    $58.8M
  • 27
    - -
  • $58.8M
  • 90/100
  • 27
  • - -
  • $58.8M
View ProfileView
3
Idorsia's Competitor - Noema Pharma logo

Ilise Lombardo

CEO

90/100
25 - 100
$201.7M
$5M - 25M
  • $201.7M
    $5M - 25M
  • 25 - 100
    $201.7M
  • $5M - 25M
  • 90/100
  • 25 - 100
  • $201.7M
  • $5M - 25M
View ProfileView
4
Idorsia's Competitor - Vifor (International) logo

CEO

- -
- -
  • - -
  • - -
  • - -
  • - -
View ProfileView
5
Idorsia's Competitor - Roche logo

Thomas Schinecker

CEO

72/100
103,605
$7.8B
$75.5B
  • $7.8B
    $75.5B
  • 103,605
    $7.8B
  • $75.5B
  • 72/100
  • 103,605
  • $7.8B
  • $75.5B
View ProfileView
Idorsia's top 22 competitors are Rhizen, Clinuvel, Noema Pharma, Novartis, Vifor (International), Roche, Biogen, Genentech, Galapagos, Amgen, Pfizer, Bristol-Myers Squibb, GSK, Merck, AstraZeneca, Abbott, GVK BIO, Cipla, Sanofi, Bayer , AbbVie and TEVA. Together they have raised over 69.5B between their estimated 1.0M employees. Idorsia has 689 employees and is ranked 19th among it's top 10 competitors. The top 10 competitors average 45,581.

Idorsia VS Rhizen

Rhizen is the biggest rival of Idorsia. Rhizen was founded in 2012, and its headquarters is in La Chaux-de-Fonds, Other. Rhizen operates in the Health Care Services industry. Rhizen has 679 fewer employees than Idorsia.

Idorsia VS Clinuvel

Clinuvel has been one of Idorsia's top competitors. Clinuvel is a Public company that was founded in Melbourne, Victoria in 2001. Clinuvel is in the Pharmaceuticals industry. Clinuvel has 662 fewer employees vs. Idorsia.

Idorsia VS Noema Pharma

Noema Pharma is Idorsia's #3 rival. Noema Pharma was founded in 2019 in Basel, Zurich. Noema Pharma is in the Biotechnology field. Noema Pharma generates $118.6M less revenue than Idorsia.

Looking for similar companies to Idorsia?

Similar Companies

Companies in Basel-Country with revenue in $100-500M range

See 11 companies 
Biotechnology companies in Allschwil

See 12 companies 
Pharmaceuticals companies in Basel-Country

See 14 companies 
Pharmaceuticals & Biotechnology companies in Allschwil

See 15 companies 
Biotechnology companies in Basel-Country

See 25 companies 
Pharmaceuticals & Biotechnology companies in Basel-Country

See 42 companies 
Biotechnology companies with employees in 500-1.0K range

See 220 companies 
Companies in Switzerland with revenue in $100-500M range

See 227 companies 
Pharmaceuticals companies with employees in 500-1.0K range

See 230 companies 

Advanced Search

PRO

Discover new companies using five search parameters, including sector, location, public/private company status, employee count, and annual revenue.

Discover new companies using five search parameters.

Trending News for Idorsia and Idorsia's Competitors

April 24, 2025Marketscreener
FRANKFURT (Reuters) -Swiss drugmaker Roche said on Thursday its first-quarter sales rose a forecast-beating 7% driven by breast cancer drug Phesgo, eye...
April 24, 2025PMLiVE
The collaboration will leverage Repertoire's immune mapping DECODE platform...
April 25, 2025Seeking Alpha
Today 12:15 PMYahoo
In This Article: Galapagos ( AMS:GLPG ) First Quarter 2025 Results Key Financial Results Revenue: €75.0m (up 20% from 1Q 2024). Net loss: €154.6m (down...
April 24, 2025Marketscreener
Bristol-Myers Squibb Company reported earnings results for the first quarter ended March 31, 2025. For the first quarter, the company reported sales wa...
April 24, 2025Benzinga
Merck & Co. Inc MRK reported the first-quarter 2025 adjusted earnings of $2.22 per share, up 7% year over year (+12% on constant currency), beating the...
April 25, 2025Crain's Cleveland Business
Amgen Inc. will invest $900 million to expand an Ohio manufacturing facility, the latest drug company to promise increased US production as the White H...
April 24, 2025Yahoo
In This Article: GALWAY , Ireland , April 24, 2025 /PRNewswire/ -- Medtronic plc (NYSE: MDT), a global leader in healthcare technology, today announced...
April 25, 2025FinanzNachrichten
Up to five-year contract extension to support the WFH Humanitarian Aid Program with medicine donations and financial assistanceSTOCKHOLM, April 25, 202...
April 25, 2025Proactive Investors
First-quarter results from GSK PLC (LSE:GSK, NYSE:GSK) will focus on commentary around the outlook, including interpretation of US policy changes under...

Frequently Asked Questions about Idorsia

  1. Who are Idorsia's top competitors?

    Idorsia's top 3 competitors are Rhizen, Clinuvel, Noema Pharma.

  2. Who is similar to Idorsia?

    Rhizen is the most similar to Idorsia. Clinuvel and Noema Pharma are also similar to Idorsia.

  1. Are Idorsia and Rhizen competitors?

    Yes, Rhizen is one of Idorsia’s top competitors.